TWINBEECH CAPITAL LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 284 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2024. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWINBEECH CAPITAL LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2023$2,966,162
+1259.6%
32,157
+563.2%
0.05%
+1100.0%
Q1 2023$218,157
-93.8%
4,849
-90.9%
0.00%
-95.7%
Q3 2022$3,528,000
+597.2%
53,549
+434.7%
0.09%
+304.3%
Q2 2022$506,000
+1.6%
10,014
+17.5%
0.02%
-88.4%
Q1 2020$498,0008,5240.20%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2024
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders